Quantifying the burden of atrial fibrillation: impact of existing and new treatments and the potential for prevention

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Atrial fibrillation (AF) causes considerable morbidity and burden to the Australian economy. We will quantify the prevalent burden and costs of hospitalised AF, ascertain the risk of major events associated with AF and the impact of existing treatments, and determine the population-attributable risk for AF due to emerging risk factors. Our data will inform clinicians and health policy makers regarding the most effective allocation of expensive health care resources to minimise the burden of AF.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2015

Funding Scheme: Project Grants

Funding Amount: $398,395.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cardiology (incl. Cardiovascular Diseases)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

atrial fibrillation | costs | epidemiology | health service utilisation | treatment outcomes